Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity

Overview
This study utilized G-Rex® to expand NK cells from cord blood using artificial antigen presenting cells (aAPCs). The protocol achieved a mean 2389-fold expansion of high-purity NK cells in 14 days. Expanded cells demonstrated significant in vitro and in vivo cytotoxicity against multiple myeloma.
What this paper found
Unselected cord blood mononuclear cells co-cultured with K562-based artificial antigen presenting cells expressing membrane-bound IL-21 and 100 IU/mL IL-2 in a GP500 gas-permeable bioreactor yielded log-scale NK cell expansion in 14 days. Twenty million MNCs were plated in 400 mL with irradiated feeders at 2:1, CD3-depleted on day 7 and restimulated 7 more days. Fresh CB (n = 8) expanded NK cells a mean 1848-fold and frozen CB (n = 6) 2389-fold, versus 20-fold for CD56-selected cells with IL-2 alone (n = 3); the product was 96% CD56+/CD3- with under 1% CD3+ cells. Expanded CB-NK cells killed myeloma lines RPMI 8226, ARP-1 and U266 in vitro; in NSG mice bearing ARP-1 myeloma, three doses of 10 x 10^6 cells extended median survival from 31 to 38 days (p = 0.003).
Note: aAPC-expanded CB-NK cells showed significantly lower surface expression of the natural cytotoxicity receptors NKp30, NKp46 and NKp44 than IL-2-expanded CB-NK cells, although KIR, NKG2A, CD94 and NKG2C expression was similar and cytotoxicity was not impaired.
Co-culture of CB MNCs with IL-2 and aAPCs yields significantly greater expansion of NK cells than culture with IL-2 alone. — Nina Shah, Beatriz Martin-Antonio, Hong Yang, Stephanie Ku, Dean A. Lee, Laurence J. N. Cooper, William K. Decker, Sufang Li, Simon N. Robinson, Takuya Sekine, Simrit Parmar, John Gribben, Michael Wang, Katy Rezvani, Eric Yvon, Amer Najjar, Jared Burks, Indreshpal Kaur, Richard E. Champlin, Catherine M. Bollard, Elizabeth J. Shpall, PLoS ONE
Study details
- Authors
- Nina Shah, Beatriz Martin-Antonio, Hong Yang, Stephanie Ku, Dean A. Lee, Laurence J. N. Cooper, William K. Decker, Sufang Li, Simon N. Robinson, Takuya Sekine, Simrit Parmar, John Gribben, Michael Wang, Katy Rezvani, Eric Yvon, Amer Najjar, Jared Burks, Indreshpal Kaur, Richard E. Champlin, Catherine M. Bollard, Elizabeth J. Shpall
- Institution
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America · Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, United States of America · Department of Pediatrics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America · Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas, United States of America · Institute of Cancer, Queen Mary University of London, Centre for Medical Oncology, Barts and The London School of Medicine, London, United Kingdom · Department of Lymphoma, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America · Department of Experimental Diagnostic Imaging, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America · Department of Leukemia Research, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America
- Journal
- PLoS ONE
- Year
- 2013
- G-Rex® model(s)
- G-Rex®100
- Cell type(s)
- NK Cells
- Application area
- Hematologic malignancy
- Study phase
- Preclinical
How G-Rex® was used
Twenty million cord blood mononuclear cells were plated in 400 mL of medium in a GP500 gas-permeable bioreactor (Wilson Wolf) with irradiated K562-based aAPC feeders at a 2:1 ratio and 100 IU/mL IL-2. On day 7 the cells were depleted of CD3+ cells and re-plated in the same conditions for 7 more days, a 14-day culture that produced log-scale NK cell expansion.
Explore related
Full citation
Shah N, Martin-Antonio B, Yang H, et al. Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity. PLoS One. 2013;8(10):e76781.
Building a similar workflow?
Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.